Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biocells (beijing) Biotech Co.,ltd

Clinical trials sponsored by Biocells (beijing) Biotech Co.,ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New stroke drug aims to cut disability in first 3 hours Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New stroke drug aims to cut disability in first 3 hours

Disease control Recruiting now

This phase 3 trial tests whether a single injection of BXOS110, given within 3 hours of an acute ischemic stroke, can reduce overall disability compared to a placebo. About 1112 adults aged 18-85 with moderate to severe stroke are being enrolled. The main goal is to see if more p…

Phase 3 • Sponsor: Biocells (Beijing) Biotech Co.,Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC